Correlation Between Lipocine and Partner Communications
Can any of the company-specific risk be diversified away by investing in both Lipocine and Partner Communications at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipocine and Partner Communications into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lipocine and Partner Communications, you can compare the effects of market volatilities on Lipocine and Partner Communications and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipocine with a short position of Partner Communications. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipocine and Partner Communications.
Diversification Opportunities for Lipocine and Partner Communications
-0.19 | Correlation Coefficient |
Good diversification
The 3 months correlation between Lipocine and Partner is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and Partner Communications in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Partner Communications and Lipocine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipocine are associated (or correlated) with Partner Communications. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Partner Communications has no effect on the direction of Lipocine i.e., Lipocine and Partner Communications go up and down completely randomly.
Pair Corralation between Lipocine and Partner Communications
If you would invest 489.00 in Lipocine on September 16, 2024 and sell it today you would earn a total of 13.00 from holding Lipocine or generate 2.66% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 4.76% |
Values | Daily Returns |
Lipocine vs. Partner Communications
Performance |
Timeline |
Lipocine |
Partner Communications |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Lipocine and Partner Communications Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Lipocine and Partner Communications
The main advantage of trading using opposite Lipocine and Partner Communications positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipocine position performs unexpectedly, Partner Communications can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Partner Communications will offset losses from the drop in Partner Communications' long position.Lipocine vs. Emergent Biosolutions | Lipocine vs. Bausch Health Companies | Lipocine vs. Neurocrine Biosciences | Lipocine vs. Teva Pharma Industries |
Partner Communications vs. Western Acquisition Ventures | Partner Communications vs. Aldel Financial II | Partner Communications vs. Lipocine | Partner Communications vs. SEI Investments |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Equity Valuation Check real value of public entities based on technical and fundamental data |